References
- Rowin EJ, Hausvater A, Link MS, et al. Clinical Profile and
Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
Circulation. 2017;136:2420-2436.
- Calkins H, Hindricks G, Cappato R, et al. 2017
HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and
surgical ablation of atrial fibrillation. Europace. 2018;20:e1-e160.
- Providencia R, Elliott P, Patel K, et al. Catheter ablation for atrial
fibrillation in hypertrophic cardiomyopathy: a systematic review and
meta-analysis. Heart. 2016;102:1533-43.
- Zheng S, Jiang W, Dai J, et al. Five-year outcomes after
catheter ablation for atrial fibrillation in patients with
hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol.
2020;31:621-628.
- Di Donna P, Olivotto I, Delcre SD, et al. Efficacy of catheter
ablation for atrial fibrillation in hypertrophic cardiomyopathy:
Impact of age, atrial remodelling, and disease progression. Europace
2010;12:347-355.
- Santangeli P, Di Biase L, Themistoclakis S, et al. Catheter ablation
of atrial fibrillation in hypertrophic cardiomyopathy: Long-term
outcomes and mechanisms of arrhythmia recurrence. Circ Arrhythm
Electrophysiol 2013;6:1089-1094.
- Bassiouny M, Lindsay BD, Lever H, et al. Outcomes of nonpharmacologic
treatment of atrial fibrillation in patients with hypertrophic
cardiomyopathy. Heart Rhythm 2015;12:1438-1447.
- Marrouche NF, Wilber D, Hindricks G, et al.
Association
of atrial tissue fibrosis identified by delayed enhancement MRI
and atrial fibrillation catheter ablation: the DECAAF study. JAMA.
2014;311:498-506.
- Kottkamp H, Schreiber D, Moser F, Rieger A. Therapeutic Approaches
to Atrial Fibrillation Ablation Targeting Atrial Fibrosis. JACC Clin
Electrophysiol. 2017;3:643-653.
- Vlachos K, Efremidis M, Letsas KP, et al.
Low-voltage areas
detected by high-density electroanatomical mapping predict recurrence
after ablation for paroxysmal atrial fibrillation. J Cardiovasc
Electrophysiol. 2017;28:1393-1402.
- Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on
diagnosis and management of hypertrophic cardiomyopathy: the Task
Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy
of the European Society of Cardiology (ESC). Eur Heart J.
2014;35:2733-79.
- Efremidis M, Vlachos K, Letsas KP, et al. Targeted ablation of
specific electrogram patterns in low-voltage areas after pulmonary
vein antral isolation in persistent atrial fibrillation: Termination
to an organized rhythm reduces atrial fibrillation recurrence. J
Cardiovasc Electrophysiol. 2019;30:47-57.
- Latif SR, Nguyen VQ, Peters DC, et al. Left atrial fibrosis correlates
with extent of left ventricular myocardial delayed enhancement
and left ventricular strain in hypertrophic cardiomyopathy. Int J
Cardiovasc Imaging. 2019;35:1309-1318.
- Sivalokanathan S, Zghaib T, Greenland GV, et al. Hypertrophic
Cardiomyopathy Patients With Paroxysmal Atrial Fibrillation Have a
High Burden of Left Atrial Fibrosis by Cardiac Magnetic Resonance
Imaging. JACC Clin Electrophysiol. 2019;5:364-375.
- Anter E, Josephson ME. Bipolar voltage amplitude: What does it really
mean? Heart Rhythm. 2015;13:326-327.
- Santangeli
P,
Hamilton-Craig
C,
Dello
Russo A, et al. Imaging of scar in patients with ventricular
arrhythmias of right ventricular origin: cardiac magnetic resonance
versus electroanatomic mapping. J Cardiovasc Electrophysiol.
2011;22:1359-66.